Efficacy markers in depression.
Current antidepressant agents are similar in efficacy to the original drugs discovered in the 1950s. The development of new treatments for depression is, however, limited by the absence of validated human biomarker models to predict efficacy, clinical profile and dosing. Such models need to meet key...
मुख्य लेखकों: | Harmer, C, Cowen, P, Goodwin, G |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2011
|
समान संसाधन
-
Efficacy markers in depression
द्वारा: Harmer, C, और अन्य
प्रकाशित: (2011) -
Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms.
द्वारा: Hayward, G, और अन्य
प्रकाशित: (2005) -
Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms
द्वारा: Hayward, G, और अन्य
प्रकाशित: (2005) -
Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.
द्वारा: Bhagwagar, Z, और अन्य
प्रकाशित: (2004) -
Elevated waking cortisol levels in neuroticism: A biological vulnerability factor for depressive disorders?
द्वारा: Portella, M, और अन्य
प्रकाशित: (2004)